Purchases and Sales Made in Q3 2022 in Syros Pharmaceuticals, Inc. (SYRS)
This table provides information about the institutional ownership of Syros Pharmaceuticals, Inc. (SYRS) during Q3 2022. The information is specifically focused on institutions that hold shares of Syros Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 09, 2022
Q3 2022
|
Ten Capital Wealth Advisors, LLC
Spokane, WA |
BUY
|
- |
219New |
$171 - $1.95K
|
219
$46
|
|
|
Nov 14, 2022
Q3 2022
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-4.59KClosed |
$3.58K - $40.9K
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-1.02M- 53.6% |
$794K - $9.06M
|
881K
$185K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.52MClosed |
$1.19M - $13.6M
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-2.88MClosed |
$2.25M - $25.7M
|
0
$0
|